[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100631461":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":29,"locations":35,"responsibleParty":65,"collaborators":67,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":78,"eligibilityCriteria":79,"healthyVolunteers":74,"sex":80,"minAge":81,"maxAge":25,"enrollmentInfo":82,"targetDuration":25,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":91,"overallStatus":56,"whyStopped":25,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Region Skane","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"L-menthol","EXPERIMENTAL","In the trial, prior to performing submaximal cardio-pulmonary exercise testing (CPET), participants will be administered, L-menthol patch which will be attached to the inside of a facemask that is connected to the breathing circuit.",[13],"Drug: L-menthol",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","For placebo, the patch will contain a similarly patch with strawberry scent.",[19],"Other: Placebo",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","(Sigma-Aldrich, St. Louis, US)",[9],null,{"type":6,"name":15,"description":27,"armGroupLabels":28,"otherNames":25},"Strawberry scent (Sigma-Aldrich, St. Louis, US)",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Zainab Ahmadi, MD, PhD","CONTACT","046171000","zainab.ahmadi@med.lu.se",[36,54],{"facility":37,"status":38,"city":39,"state":40,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Blekinge Institute of Technology","NOT_YET_RECRUITING","Karlskrona","Blekinge County","Sweden","SE",{"type":44,"coordinates":45},"Point",[46,47],15.58661,56.16156,{"lat":47,"lon":46},[50],{"name":51,"role":32,"phone":52,"phoneExt":25,"email":53},"Jacob Sandberg, MD, PhD","+46 (0)455-38 54 09","jacob.sandberg@bth.se",{"facility":55,"status":56,"city":57,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Lund University hospital and Region Skåne","RECRUITING","Lund",{"type":44,"coordinates":59},[60,61],13.19321,55.70584,{"lat":61,"lon":60},[64],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},{"type":66,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[68,69],{"name":37,"class":6},{"name":70,"class":71},"Blekingesjukhuset, Karlskrona","UNKNOWN","100631461","phase-2-efficacy-of-l-menthol-on-breathlessness-in-asthma-100631461",false,"NCT07500974","Efficacy of L-menthol on Breathlessness in Asthma","Effect of L-menthol on Breathlessness and Exercise Capacity in Asthma: a Randomized Crossover Trial","Ment-Astma","Inclusion Criteria:\n\n* the subject has given written consent to participate in the study\n* physician diagnosis of Asthma according to international guidelines\n* mMRC (modified Medical Research Council) score of 1 or above\n* age 18 years or older\n* able to cycle\n* able to understand and talk Swedish to participate in the study procedures, as judged by the Investigators.\n\nExclusion Criteria:\n\n* resting peripheral oxygen saturation (SpO2) \\\u003C 92%\n* hospitalization or clinical instability during the last four weeks\n* treatment with supplementary oxygen at rest or during exercise\n* contraindication to exercise testing in accordance with clinical practice guidelines\n* expected survival shorter than six months as judged by the Investigator\n* medical conditions including congestive heart failure, acute coronary artery disease, neuromuscular diseases, severe psychiatric illness, and olfaction disorder.","ALL","18 Years",{"count":83,"type":84},20,"ESTIMATED","INTERVENTIONAL",[87],"PHASE2","The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Asthma.",[90],"Asthma",[92,93,94,95],"breathlessness","asthma","exercise capacity","CPET","2026-08-17",{"date":98,"type":99},"2026-08-19","ACTUAL",{"date":101,"type":99},"2026-05-07",{"date":103,"type":84},"2027-05",{"name":5,"class":6},2]